BioSpace News Archive

23andMe, Inc., the leading personal genetics company, today received FDA clearance for a genetic health risk report on a hereditary colorectal cancer syndrome.

Aether, the pioneer of AI enhanced 3D bioprinting, has announced a collaboration with researchers from University College London (“UCL”) and Loughborough University to develop a powerful new approach to 3D printing nanotechnology.

Kellogg’s* Special K* is taking a stand on women’s health and introducing Escape the Nonsense, Canada’s first interactive pop-up of its kind that invites Canadian women to ditch the nonsense on their health journey and own every bite of life.

Honoring half a century of significantly impacting the lives of dentists and their patients, the Institute kicks off a year-long celebration.

Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal 2019 financial results after the stock market closes on February 20.

Brand announces several digital initiatives to remind consumers that Avocados From Mexico are Always Worth It

For the sixth consecutive year, Cancer Treatment Centers of America® (CTCA) Chicago has been recognized as a top center in the country for providing quality breast cancer care by the National Quality Measures for Breast Centers (NQMBC®) program.

Phacilitate Leaders World and World Stem Cell Summit at Hyatt Regency Miami, January 22-25 #WSCS2019 and #PLW2019

evo ACS™ Extends Thermal Protection During Shipment of Patients’ T Cells for Downstream Manufacturing of CAR T-Cell Therapies

Mark Lashley, President and CEO of Caregiver, Inc., is disrupting an outmoded industry-wide model of contracting with outside companies for behavioral supports for their clients, an approach that suffers from disparate contractors and inconsistent, rotating outside staff that too often submits Caregiver clients to less-than-optimum experiences.